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AbstractSaliva contains a number of antimicrobial substances which have their origin either in salivary glands or serum from 
which they may leak into the mouth via the gingival crevices. Saliva is believed to possess a substantial influence on the aggregates oral pathogens form in the mouth due to the antibodies as well as proteins whose antimicrobial properties do not depend on prior exposure to an antigen. One such enzyme is Lysozyme which is one of the most powerful natural antibacterial and antiviral compounds known to man. According to previous researches, it has been found out that lysozyme may bind and aggregate Gram-positive bacteria such as putative Gram-negative periodontopathic bacteria such as Capnocytophaga gingivalis. This particular study explores the natural phenomenon Lysozyme exhibits against oral 
microflora with noteworthy conclusions. Saliva samples were collected from the oral cavity of human, cow and dog. From 
these samples, lysozyme was isolated and purified. Furthermore, the quantity of the enzyme isolated was ascertained by 
Polyacrylamide Gel Electrophoresis. The quantified enzyme showed 32kDa for cow sample, 23kDa for dog sample and 
23kDa for human sample. Finally the antimicrobial activity of the enzyme was determined by agar well diffusion method against Staphylococcus spp. and Enterococcus faecalis. Hence lysozyme in saliva is found to have the antibacterial activity against the pathogen due to the zone of inhibition observed and this proves that a tool to prevent dental decay is available 
and that there is potential to serve antimicrobial role in the specific application of medical industry.
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1. Introduction
Saliva is an essential fluid for the health of human teeth 
and mucosal surface. The basic protective mechanism 
mediated by saliva is bacterial but saliva contains also a 
number of antimicrobial substances which have their ori-
gin either in salivary glands or serum from which they 
may leak into the mouth via gingival crevices scattered 
aggregation of lymphoid tissue at various sites in the 
human mouth and also produce protective agents. Both 
the salivary glands contain antibodies as well as proteins 
whose antimicrobial properties do not depend upon prior 
exposure to an antigen non-immunoglobulin defense fac-
tor .many of these factors are common to most human 
external secretions e.g., milk, tears and saliva share a very 
similar pattern of antimicrobial agents. Especially lyso-
zyme, lactroferrin and peroxidise enzyme are found in 
substantial concentration in all secretions. 1Lysozymes, 
also known as mermaids, are compounds that help break 
the complex chemical bonds by hydrolysis. These bio-
catalysts hydrolyze the NAM and NAG residues in the 
cell wall of Chitodextrins. Body discharges like tears, 
saliva, human milk, and mucus have good amounts of the 
enzyme and Lysozyme is also predominant in egg white, 
macrophages and Poly nuclear neutrophils. Lysozyme 
activity may result from activation of endogenous bacte-
rial lytic enzyme(s) by the lysozyme-chloride complex. 
The enzyme has been reported in the past thirty years to 
act very effectively against bacteria and viruses thereby 
increasing the shelf-life of food products and helps avoid 
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spoilage and accomplishes food safety. Due to this fact, 
Lysozyme is known to increase immunity and therefore is 
reported to be used in pediatric foods and in patients suf-
fering from gastro problems. Lysozyme has been widely 
used for over 50 years as an “endogenous antibiotic” in 
the pharmaceutical industry. It treats and prevents a 
variety of conditions, particularly viral and bacterial 
infections, and is especially effective as a prescription 
drug for use in the treatment of viral forms, localized or 
systemic inflammatory processes and gastrointestinal dis-
turbances, mostly in formula fed infants. This important 
biocatalyst has been used as a marker in various infections 
in humans. It is also used as an indicator of health and 
infection in animals and humans, for patients with ulcers, 
erysipelas and microbial eczema. This 14-kDa basic pro-
tein lyse the outer wall of bacteria by destroying the 1,4 
glycoside linkages between N-acetylmuramic acid and N 
acetyl glucosamine of the peptidoglycan. Members of the 
normal oral flora have been found to be relatively insensi-
tive to lysis by lysozyme2. However, lysozyme may bind to 
aggregate Gram-positive bacteria such as Streptococcus 
mutans, other streptococci and putative Gram-negative 
periodontopathic bacteria such as Capnocytophaga gingi-
valis. Binding is thought to involve cationic portions of 
the molecule interacting with anionic bacterial surface 
components, as well as specific recognition of bacterial 
cell wall sugars by the enzyme-active site. The addition 
of sodium chloride to aggregated bacteria insensitive to 
muramidase activity leads to cell lysis, perhaps by the 
activation of endogenous bacterial lytic enzyme(s) by 
the lysozyme-chloride complex. Lysozyme is also known 
to inhibit glucose fermentation by oral streptococci3-5. 
Dental plaque is consider to be one of the major disease 
which is caused by multidrug resistant bacteria and the 
saliva of the animals finds the solution to it by inhibiting 
those bacteria. The saliva of the cow, dogs, human con-
tains lysozyme which are very effective and responsible 
for the inhibition of the bacteria and hence it is consid-
ered to prevent dental plaque6. Thus the efficiency of the 
anti-bacterial properties of Lysozyme in all three samples 
is determined through this study.
2. Materials and Methods
2.1 Collection of Sample 
A total of 25ml of saliva was collected from the oral 
cavity of human, cow and dog using sterile buds and was 
collected in a sterile test tube with 5ml of saline (0.02gm 
of NAOH in 10 ml of distilled water)4. Then the sample 
was stored in a refrigerator.
2.2 Isolation and Purification of Lysozyme
The saliva was then centrifuged for 5 minutes at 4°c at 
10,000 rpm. The supernatant was collected and to it 0.2% of 
sodium azide was added and was stored at 4°c. Cautiously 
and aseptically prepared 50% ml of Polyethylene Glycol 
(PEG) and 30% of sodium sulfate were added to the above 
supernatant and stabilized at a pH of 9.0. After that the 
sample was incubated for 1hr and centrifuged at 10,000 
rpm for 20 min. The formed fractions were dialyzed sepa-
rately against Phosphate Buffer Saline (PBS) pH 7 and then 
analyzed for the concentration and lysozyme activity7.
2.3 Quantification of the Enzyme
Using 15% of SDS-PAGE and recommended stain 
(Coomasie Blue) the molecular weight was determined 
using standard procedure.
2.4  Reagents for Antimicrobial Activity 
Disc Diffusion Method
About 38.0 grams of Muller Hinton agar medium and 5.0 
grams of Agar-Agar was suspended in 1000ml of distilled 
water and the prepared medium was autoclaved at 15 lbs 
pressure 121ºC for 15 minutes.
2.5  Preparation of Agar Plates for 
Antimicrobial Activity 
For antibacterial activity, freshly prepared Muller Hinton 
agar was poured into a petri plate depth of about 4 mm. 
The agar medium was allowed to cool to room tempera-
ture and stored at 4ºC.
2.6 Inoculum Preparation 
The isolates of bacterial culture are used as strains. A loop 
of single colony of each test strain was grown overnight 
containing Brain Heart Infusion medium on a shaker (150 
rpm) at 35⁰C.
2.7 Inoculation of Test Plate 
Sterilized cotton swab was introduced into the bacterial 
inoculum so that culture is absorbed onto the swab. The 
swab with culture is then used to make a lawn culture 
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8. Remove unnecessarily accumulated water.
2.10 Stacking or Upper Gel 
1. Similarly, The gel is prepared as follows:
 Dist. Water 1700µl
 30% Acrylamide 410µl
 0.5M Tris (pH6.8) 310µl
 Double Distilled Water 25µl
2. Subjected to vacuum for 5 min and add the TEMED 
and APS as follows. 
 10% APS 25µl
 TEMED 2.5µl
3. Mix the solution quickly and avoid bubble formation 
and dispense the solution between the glass plates 
above the separating gel.
4. Using the Teflon Comb insert it carefully to avoid 
bubbles and leave the setup undisturbed for 45-60 
minutes to let the stacking gel form a complex. 
5. Remove the comb cautiously and flush the wells to 
wash using a needle.
3. Results and Discussion
3.1 Estimation of Total Protein 
Overall protein content in saliva as well as the isolated 
lysozyme was estimated by measurement of the absor-
bance at 280 nm in UV-Vis spectrophotometer. And 
the absorbance of the samples was found to be human 
(0.419nm), cow (0.314nm) and dog (0.292nm).
Protein was separated using SDS-PAGE and is possi-
bly the globally accepted method. 
over the entire agar surface in a petri dish so that an even 
distribution of inoculum is obtained.
2.8 Protein Separation by SDS-PAGE
Sodium Dodecyl Sulphate (SDS) is an anionic detergent 
which denatures proteins by enveloping the polypeptide 
central supporting chain, SDS binds to proteins and delib-
erates a negative charge to the polypeptide so that a cloud 
with equal charge or charge is formed. The disulphide 
bridge are reduced by dithiothreitol. The polymer com-
plex when formed turns into gel and by using electricity 
the proteins are pulled through the gel, the entire process 
is called Polyacrylamide Gel Electrophoresis (PAGE). The 
electrophoresis proteins can be suitably be seen by the 
stain like Coomassie blue or silver nitrate etc. (Figure 1).
2.9 Gel Casting
1. The cleaned glass plates with given spacers is arranged.
2. Preparation of Separating/lower gel:
 30% Acrylamide 5.5ml
 1.5M Tris (pH 8.8) 3.75ml 
 10% SDS 150µl
 Double Distilled Water 6ml 
3. The filter is mixed and subjected to vacuum for 5 min.
4. Catalyst:
 10% APS 150 µl
 TEMED 13µl
5. Mix the solution quickly and avoid bubble formation. 
6. Dispense the prepared gel in between the glass plates 
and allowing enough space for Stacking gel. Cover the 
separating gel so that no atmospheric air comes into 
contact. 
7. Let the setup be undisturbed for 45-50 mins.
Figure 1. Sodium Dodecyl Sulphate - Poly Acrylamide Gel Electrophoresis (SDS-PAGE) Apparatus setup. 
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The protein is therefore quantified. Further, the analy-
sis proved to be quite noteworthy as the values were found 
to be 32KDa for Cow sample, 23KDa for Dog sample and 
23KDa for Human sample, interestingly similar to that of 
a Dog.
3.2 Antimicrobial Activity 
Four wells are made in each of the Petri plates that were 
swabbed with bacteria. Different concentrations (25µl, 
50µl, 75µl, 100µl) of the Lysozyme are added in three wells 
respectively. Similarly done with the saliva of human, cow 
and dog.
The inoculated plates were incubated for 24hrs and 
it was observed that various zones of inhibition were 
obtained. These zones were uniformly circular. The diam-
eter of the zones was not of importance but the formation. 
The zones were conspicuous and therefore noteworthy. 
4. Conclusion
Many antimicrobial agents are understood to possess bac-
teriostatic or bactericidal effects on mutants. Very little 
proof exists to show that they also affect oral cariogenic 
flora invivo. Recent studies have shown that some sali-
vary systems can act synergistically against Streptococcus 
mutans the principle etiology of Dental caries. Such 
synergy is likely to be present in the oral cavity. Earlier 
studies have attempted to study proteins such as per-
oxidase, lactoferrin, and the enzyme used in the present 
study, lysozyme to oral health products5-9. Although clini-
cal evidence is still limited, the concocted idea that such 
antimicrobial agents can be used as “natural antibiotics”, 
Figure 2. SDS TRIAL RUN.
Figure 4. Zone of inhibition due to Antimicrobial activity observed by Lysozyme on microorganisms Staphylococcus sps. and 
Enterococcus foecalis.
(a) (b) (c)
Figure 3. Results of SDS PAGE. (a) Control (b) Cow 
sample (c) Dog sample (d) Human.
(d)
Antimicrobial Activity of Lysozyme Against Oral Pathogens
Asian Journal of Pharmaceutical Research and Health Care46 Vol 8 (2) | 2016 | www.informaticsjournals.org/index.php/ajprhc 
as an alternatives to health detrimental synthetic agents 
against cariogenic bacteria seems a promising research 
prospect. The mammalian body have been blessed with 
ultimate innate defense factors in saliva such as Lysozyme 
and Lactoferrin, these contribute hugely to mucosal secu-
rity and control certain microbial populations in the oral 
cavity, especially Candida spp.10-12. On the other hand, 
Histatins are important constituents of the salivary pro-
teins which possess substantial defence mechanisms for 
patients with salivary dysfunction. It is seen that Saliva 
exhibits multiple host defense functions such as homeo-
static processes, lubrication, antimicrobial activity and 
the control of demineralization of teeth. Hence, lysozyme 
in saliva is found to have the antibacterial activity against 
the pathogen since it shows the zone of inhibition and it 
is proved to prevent the dental plaque. We believe that the 
work presented in this study suggests that lysozyme has 
the potential to serve such a role in the specific applica-
tion of medical industry.
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